Institute Of Liver & Biliary Sciences
An Autonomous Institute
under Government of NCT of Delhi
 
 
SPEAKERS IN SYMPOSIUM

Dr. Riad Salem MD, MBA
Professor of Radiology, Medicine and Surgery
Director, Interventional Oncology
Division of Interventional Radiology
Department of Radiology
Northwestern University
676 N St Clair, Suite 800
Chicago, IL 60611

Dr. Vijay Kumar
Staff Research Scientist
Virology Group
International Center for Genetic
Engineering & Biotechnology (ICGEB)
Aruna Asaf Ali Marg
New Delhi-110067, INDIA


Dr. Samir Shah is a
Consultant Hepatologist
attached to Jaslok
Hospital and Research
Centre. After finishing
M.D. in medicine from
Grant Medical College,
Bombay in 1982,
he was the selected
to do a two-years
degree course in
Gastroenterology at
the Christian Medical
College, Vellore.
He has been a
member of the
Editorial Board of
Indian Journal of
Gastroenterology and
was elected as the
Secretary of the
Indian Association for
study of the liver
for the period
1995-1997.

Dr. AJAI KHANNA
Professor of Surgery
University of California, San
Diego Director Pediatric
Abdominal Transplant Programs
Rady Children’s Hospital
of San Diego

Prof. Mohandas K. Mallath, M.D.
Dean-Academic Tata Memorial
Centre Head, Department of
Digestive Diseases and
Clinical Nutrition
Room 24, Main Building
Tata Memorial Hospital
Mumbai 400012, India

Henry Masur, M.D.
Chief Critical Care Medicine
Department Warren Magnuson
ClinicalCenter National Institutes
of Health Bethesda, Maryland

Atul, Patel K.
Chief consultant; Infectious
Diseases clinic Infectious
Diseases Clinic, 3rd Floor,
“VEDANTA” Institute of Medical
Sciences. Navarangpura.
Ahmedabad. 380 009
MEMBERS
Username
Password
Lost Password?
Hepatitis Virus-HIV Co-Infections and HCC
New Management Paradigms in Liver Diseases
 
MARCH 6, 2010, (Saturday) Registration 8.15-9.00 AM
TITLE SPEAKER  TIME (MIN)
Welcome Address S K Sarin 9.00
Over view/Objectives of the Meeting Shyam Kottilil  
Inaugural Address V M Katoch  
Session I.  HIV – HCV/HBV  COINFECTION   
Changing Paradigms of Opportunistic Infections in
HIV Disease
H.Masur 9.15
Screening, Diagnosis, and Selecting Patients for Treatment Sanjay Bhagani 9.35
Immunological Basis of Liver Injury in Hepatitis (HBV,HCV)-HIV Coinfections Shyam Kottilil 10.00
HIV and  Hepatitis C Fibrosis Progression
Natural course of Chronic HCV; Impact of HIV on natural course of chronic HCV; Mechanisms of increased fibrogenesis and carcinogenesis in HIV coinfected chronic HCV.
David Kleiner 10.25
Treatment of Hepatitis C in the HIV-Infected Patient
Which infection to treat first; Therapies available,response predictors,optimal dose and duration; Nonresponders and relpsers; Acute HCV; Interactions between anti-HIV drugs and those for hepatitis C
Mike Polis 10.50
Break   11.15
HIV and Hepatitis B Virus Interactions
Natural course of Chronic HBV; Imfluence of HIV on  HBV-diagnosisi, vaccination, fibrosis progression, response.
Rajan Koshy 11.40
Screening, Diagnosis, and Selecting Patients for Treatment TBA 12.05
Treatment of Hepatitis B in the HIV-Infected Patient
Which infection to treat first; Therapies available, optimal dose and duration; Interactions between anti-HIV drugs and those for hepatitis B.
Theo Heller 12.30
Lunch Symposium   13.00
Hepatotoxicity of Antiretroviral Drugs TBA 14.15
Liver Transplant in HIV.HCV-HBV Co-Infection Ajai Khanna 14.40
Application of Bioinformatics in the Management of HCV Richard Lempicki 15.05
Coffee   15.30
Session II: HEPATOCELLULAR CARCINOMA  
Screening Controversaries For HCC: West vs. East Sameer Shah 15.55
Molecular Classification and Biomarkers and Molecular Targets in HCC Wang X W 16.20
Molecular Mechanisms in Pathogenesis of HCC Vijay Kumar 16.45
Small HCC – New Diagnostic Modalities Aradhana 17.10
Dinner Syposium : Mc Hutchinson 7.00